Skip to main content

Table 3 Outcomes

From: Thyroid hormones and functional outcomes after ischemic stroke

 

TSH

fT3

fT4

Discharge outcomes

   

  Death in hospital

 

NS

NS

   Died

0.5245 (0.303–0.761)*

  

   Alive

1.275 (0.75–1.9875)*

  

  Death in hospital or hospice vs alive

NS

 

NS

   Death or hospice

 

1.99 (1.74–2.475)*

 

   Alive

 

2.47 (2.13–2.95)*

 

3 month outcomes

   

  Death vs alive at 3 months

 

NS

NS

   Death

0.66 (0.372–1.45)*

  

   Alive

1.27 (0.75–2.11)*

  

  Independence level

NS

 

NS

   mBI > 15, independent

 

2.53 (2.24–2.99)**

 

   mBI < 14, dependent

 

2.06 (1.85–2.6)**

 

   Poor outcome, mRS > 3 or death

0.873 (0.586–1.48)*

  

   Favourable outcome, mRS < 2

1.54 (0.6575–2.255)*

  

12 month outcomes

   

   mRS score

NS

R = −0.268*

NS

   mBI > 15, independent

 

2.525 (2.26–2.965)*

 

   mBI < 14, dependent

 

2.175 (1.865–2.823)*

 

   Poor outcome, mRS > 3 or death

 

2.04 (1.825–2.485)***

 

   Favourable outcome, mRS < 2

 

2.62 (2.32–2.97)***

 
  1. Patients with better acute and long term outcomes had higher TSH levels, and higher fT3 levels at 3 and 12 months post-stroke. No associations were seen between acute and long term outcomes with fT4
  2. *p < 0.05; **p < 0.01; ***p < 0.001